This is the authors' abstract. We don't add key points for this paper.
Aim Sensitive and convenient methodologies for detection of influenza A/B viruses and SARS-CoV-2 are of great importance for further disease control and treatment. This study aimed to establish a rapid, sensitive and specialized instrument-free method for the detection of these viruses.Materials & methods We developed a multiplex Multienzyme Isothermal Rapid Amplification (MIRA) assay for simultaneous amplification of influenza A/B viruses and SARS-CoV-2. The amplicons were further detected by CRISPR/Cas13a. And the signal was finally detected using a novel magnetic bead-quantum dot (MBQD) sensor based on the integrity of the Link-Probe.Results The established integrated assay (known as MMIRA-CRISPR/Cas13a-MBQD) could be completed within 60 minutes, and the limit of detection (LOD) was determined to be 1, 2, and 56 copies of RNA for SARS-CoV-2, influenza A, and influenza B, respectively. No cross-reactivity with other respiratory pathogens was found. Clinical sample analysis showed the MMIRA-CRISPR/Cas13a-MBQD assay had an overall sensitivity and specificity of 98.8% and 100%, respectively. Good agreement was observed between the assay and real-time RT-PCR (p = 0.988).Conclusion The established assay is a promising tool for the detection of influenza A/B viruses and SARS-CoV-2. No expensive instrument required makes this assay more suitable for use in resource-limited settings.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: